Kovacs, R. J., Maldonado, G., Azaro, A., Fernández, M. S., Romero, F. L., Sepulveda-Sánchez, J. M., . . . Lahn, M. M. (2014). Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study. Cardiovasc Toxicol.
Chicago Stili AlıntıKovacs, Richard J., et al. "Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study." Cardiovasc Toxicol 2014.
MLA AlıntıKovacs, Richard J., et al. "Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study." Cardiovasc Toxicol 2014.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..